252 related articles for article (PubMed ID: 15848274)
1. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
Viner KM; Isaacs SN
Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy.
Pütz MM; Alberini I; Midgley CM; Manini I; Montomoli E; Smith GL
J Gen Virol; 2005 Nov; 86(Pt 11):2955-2960. PubMed ID: 16227216
[TBL] [Abstract][Full Text] [Related]
3. Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination.
Pütz MM; Midgley CM; Law M; Smith GL
Nat Med; 2006 Nov; 12(11):1310-5. PubMed ID: 17086190
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
6. Serological responses in humans to the smallpox vaccine LC16m8.
Johnson BF; Kanatani Y; Fujii T; Saito T; Yokote H; Smith GL
J Gen Virol; 2011 Oct; 92(Pt 10):2405-2410. PubMed ID: 21715598
[TBL] [Abstract][Full Text] [Related]
7. Extracellular enveloped vaccinia virus escapes neutralization.
Ichihashi Y
Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
[TBL] [Abstract][Full Text] [Related]
8. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
Kaufman DR; Goudsmit J; Holterman L; Ewald BA; Denholtz M; Devoy C; Giri A; Grandpre LE; Heraud JM; Franchini G; Seaman MS; Havenga MJ; Barouch DH
J Virol; 2008 Jul; 82(14):6829-37. PubMed ID: 18448519
[TBL] [Abstract][Full Text] [Related]
9. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.
Hatakeyama S; Moriya K; Saijo M; Morisawa Y; Kurane I; Koike K; Kimura S; Morikawa S
Clin Diagn Lab Immunol; 2005 Apr; 12(4):520-4. PubMed ID: 15817760
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
11. Extracellular enveloped vaccinia virus. Entry, egress, and evasion.
Smith GL; Vanderplasschen A
Adv Exp Med Biol; 1998; 440():395-414. PubMed ID: 9782308
[TBL] [Abstract][Full Text] [Related]
12. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
[TBL] [Abstract][Full Text] [Related]
13. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
[TBL] [Abstract][Full Text] [Related]
14. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
[TBL] [Abstract][Full Text] [Related]
15. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.
Newman FK; Frey SE; Blevins TP; Mandava M; Bonifacio A; Yan L; Belshe RB
J Clin Microbiol; 2003 Jul; 41(7):3154-7. PubMed ID: 12843056
[TBL] [Abstract][Full Text] [Related]
16. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
17. An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.
Law M; Pütz MM; Smith GL
J Gen Virol; 2005 Apr; 86(Pt 4):991-1000. PubMed ID: 15784892
[TBL] [Abstract][Full Text] [Related]
18. The smallpox vaccine induces an early neutralizing IgM response.
Moyron-Quiroz JE; McCausland MM; Kageyama R; Sette A; Crotty S
Vaccine; 2009 Dec; 28(1):140-7. PubMed ID: 19822230
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.
Midgley CM; Putz MM; Weber JN; Smith GL
J Gen Virol; 2008 Dec; 89(Pt 12):2992-2997. PubMed ID: 19008384
[TBL] [Abstract][Full Text] [Related]
20. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
